SEC Form 4 · accession 0001349929-16-000130
CANCER GENETICS, INC · CGIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward J Sitar
Officer — Chief Financial Officer
Period of report
Nov 16, 2016
Accepted (ET)
Nov 16, 2016 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001349929
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share | Nov 16, 2016 | S | 3,333 | $1.558 | D | 14,167 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale due to pending tax obligation.